The most eye-catching recent filing came from SMMT. Summit Therapeutics Chairman and CEO Robert Duggan filed a $50M purchase on June 12. That's 3.8 million shares at $13.12 each. It signals strong personal conviction from the man running the company.
Over at NCLH, Director Steve Pagliuca filed two back-to-back buys totalling nearly $25M. He picked up 1.38 million shares in early June at around $18. That's a notable bet on the cruise operator's recovery story.
On the sell side, NVDA Director Mark Stevens filed $186M in sales on June 23. The trades took place June 18 at around $210 per share. That's a large exit near all-time highs.
ASTS founder and CEO Abel Avellan filed a $146.7M sale on June 23. He sold 2.5 million shares at $58.68. AST SpaceMobile has more than doubled this year, making it a natural point to take profits.
BBY founder Richard Schulze filed two sales totalling over $32M this past week. He sold at roughly $78 per share. Best Buy shares have climbed this year and Schulze appears to be trimming his long-held position.
WMT saw the Walton Family Holdings Trust file $533M in combined sales on June 18. The trades occurred June 16 at around $121 per share — routine for a family office managing a massive position, but still notable in scale.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
